Glycolytic Heterogeneity Drives Metabolic-Targeted Therapy in Pancreatic Ductal Adenocarcinoma

Scientists investigated whether glycolytic activity follows a consistent expression pattern across pancreatic ductal adenocarcinoma patients and explored how metabolic diversity influences therapeutic responses.